BCNI Blood Cancer Symposium - Friday 28th May 2021 Virtual Event

Apr 27 2021 Posted: 12:30 IST

Blood Cancer Network Ireland is holding its annual symposium  on Friday 28th May 

 

The aim of the symposium is to provide Irish researchers and clinical staff with the opportunity to hear about the latest research and hottest topics in blood cancer research from international experts and to present their own work in this area.

This symposium will bring researchers in the fields of cancer drug discovery and hematological malignancies together with industry and clinical investigators interested in translating research findings into early clinical development.

The scientific focus will be in three key areas:

  • Childhood Leukemia
  • Diagnosis and disease monitoring
  • Lymphoma

The focus of the symposium on cutting edge research and cancer therapeutics development will make this a highly significant and relevant meeting for all researchers interested in applying research findings for clinical development in blood cancers.

Register for this free event here: https://nuigalwaybcni.clr.events/

 Schedule:

TIME Speaker & Topic

9:15 

Prof. Jonathan Bond- Acute Leukaemia: lessons from the Haematopoietic Roadmap

9:50 

Prof. Owen Smith- Child, adolescent and young adult cancers (NCCP perspective)

10:25 

10:35

Short talk- Andrea Malone- Paediatric relapsed/refractory ALL- European Phase 1 study on inotuzumab.

Short talk- Peter McCarthy- Searching for targetable gene fusions in childhood leukaemia.

10:45 

BREAK

11:00 

Dr. Richard Dillon- Molecularly guided interventions to prevent relapse in AML

11:35 

Dr. Bruno Paiva- Disease monitoring in multiple myeloma

12:10 

Dr. Mairead O'Connor- Using qualitative research to understand the needs of lymphoma survivors

12:50

Short talk- Dawn Swan-TBC

13:00 

LUNCH

14:00 

Prof. Elisabeth Vandenberghe- Mantle cell lymphoma; the dialogue between translational and clinical research

14:40 

Prof. Paul Murray- Pre-recorded: Lymphoma, New insights into the microenvironment of diffuse large B cell lymphoma. Dr. Matt Pugh Q&A

15:20 

Short talk- Dr. Daniel Angelov- Short Talk: Outcome of National Allogenic Transplantation Program in Mycosis Cutaneous T cell Lymphoma (CTCL): a 10 year experience

 

 

 

 

Updated draft symposium programme  

 

PreviousNext